Related Experiment Video
Updated: Dec 29, 2025

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Magnetic Resonance Cholangiopancreatography Severity Predicts Disease Outcomes in Pediatric Primary Sclerosing
Kedar Patil1,2, Amanda Ricciuto3,4, Alaa Alsharief1
1Department of Diagnostic Imaging The Hospital for Sick Children Toronto Canada.
Abstract:
Magnetic resonance cholangiopancreatography (MRCP) has not been assessed as a surrogate biomarker in pediatrics. We aimed to determine the inter-rater reliability, prognostic utility, and construct validity of the modified Majoie endoscopic retrograde cholangiopancreatography classification applied to MRCP in a pediatric primary sclerosing cholangitis (PSC) cohort. This single-center, retrospective, cohort study included children with PSC undergoing diagnostic MRCP between 2008 and 2016. Six variations of the Majoie classification were examined: 1) intrahepatic duct (IHD) score, 2) extrahepatic duct (EHD) score (representing the worst intrahepatic and extrahepatic regions, respectively), 3) sum IHD-EHD score, 4) average IHD score, 5) average EHD score, and 6) sum average IHD-EHD score. Inter-rater reliability was assessed using weighted kappas and intraclass correlation coefficients (ICCs). Ability to predict time to PSC-related complications (ascites, esophageal varices, variceal bleed, liver transplant [LT], or cholangiocarcinoma) (primary outcome) and LT (secondary outcome) was assessed with Harrell's concordance statistic (c-statistic) and univariate/multivariable survival analysis. Construct validity was further assessed with Spearman correlations. Forty-five children were included (67% boys; median, 13.6 years). The inter-rater reliability of MRCP scores was substantial to excellent (kappas/ICCs, 0.78-0.82). The sum IHD-EHD score had the best predictive ability for time to PSC complication and LT (c-statistic, 0.80 and SE, 0.06; and c-statistic, 0.97 and SE, 0.01, respectively). Higher MRCP scores were independently associated with a higher rate of PSC-related complications, even after adjusting for the PSC Mayo risk score (hazard ratio, 1.74; 95% confidence interval, 1.14-2.). MRCP sum scores correlated significantly with METAVIR fibrosis stage, total bilirubin, and platelets (r = 0.42, r = 0.33, r = -0.31, respectively; P < 0.05). Conclusion: An MRCP score incorporating the worst affected intrahepatic and extrahepatic regions is reliable and predicts meaningful outcomes in pediatric PSC. Next steps include prospective validation and responsiveness assessment.
Insights
Magnetic resonance cholangiopancreatography (MRCP) scores are reliable for assessing pediatric primary sclerosing cholangitis (PSC). An MRCP score combining intrahepatic and extrahepatic duct information predicts complications and liver transplant needs in children with PSC.
Area of Science:
- Pediatric Gastroenterology and Hepatology
- Medical Imaging and Diagnostics
- Biomarker Development
Background:
- Magnetic resonance cholangiopancreatography (MRCP) has not been validated as a surrogate biomarker in pediatric primary sclerosing cholangitis (PSC).
- Assessing disease severity and predicting outcomes in pediatric PSC is crucial for timely intervention.
Purpose of the Study:
- To evaluate the inter-rater reliability, prognostic utility, and construct validity of a modified Majoie classification applied to MRCP in pediatric PSC.
- To determine if MRCP scores can predict disease complications and the need for liver transplantation.
Main Methods:
- Retrospective cohort study of 45 children with PSC undergoing MRCP.
- Six variations of the Majoie classification were applied to MRCP images.
- Inter-rater reliability assessed using weighted kappas and ICCs; prognostic utility evaluated using survival analysis and c-statistics; construct validity assessed via Spearman correlations.
Main Results:
- MRCP scores demonstrated substantial to excellent inter-rater reliability (kappas/ICCs, 0.78-0.82).
- The sum intrahepatic and extrahepatic duct (IHD-EHD) score showed the best predictive ability for PSC complications (c-statistic, 0.80) and liver transplant (LT) (c-statistic, 0.97).
- Higher MRCP scores were independently associated with increased PSC complications and correlated significantly with fibrosis stage and bilirubin levels.
Conclusions:
- An MRCP-based score, incorporating the most affected intrahepatic and extrahepatic duct regions, is reliable and prognostic in pediatric PSC.
- This MRCP scoring system can predict meaningful clinical outcomes, including disease progression and liver transplant necessity.
- Further prospective validation and responsiveness assessment are recommended for this novel biomarker.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Endoscopic Procedures V: ERCP
Patient...
